Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.

@article{Rollnik2001NeutralizingBT,
  title={Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.},
  author={Jens Dieter Rollnik and Kai Wohlfarth and Reinhard Dengler and Hans Bigalke},
  journal={Neurology & clinical neurophysiology : NCN},
  year={2001},
  volume={2001 3},
  pages={2-4}
}
Neutralization of antibodies poses a problem for a substantial number of cervical dystonia (CD) patients treated with botulinum toxin type A (BoNT/A). Presence of these antibodies may lead to a secondary nonresponse to BoNT/A treatment. In this study, we compared 6 antibody-positive (Ab+) with 12 antibody- negative (Ab-) CD patients treated with BoNT/A (Dysport) and matched for du- ration of treatment, number of BoNT/A injections, and severity of clinical symptoms. The two groups differed in… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Development of antibodies to botulinum toxin type A in torticollis patients treated with botulinum toxin injection

  • P Greene, S Fahn
  • Mov Disord
  • 1992

Similar Papers

Loading similar papers…